论文信息 - Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia chromosome/BCR-ABL1 positive acute Lymphoblastic Leukemia (ALL): A trial of the European Working Group for Adult ALL (EWALL-PH-02) - 字舞流文

Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia chromosome/BCR-ABL1 positive acute Lymphoblastic Leukemia (ALL): A trial of the European Working Group for Adult ALL (EWALL-PH-02)

N. Schmitz | J. Cayuela | H. Dombret | K. Spiekermann | J. Panse | S. Leprêtre | G. Guillerm | C. Junghanss | P. Rousselot | J. Ribera | F. Suarez | O. Ottmann | D. Hoelzer | A. Reichle | E. Raffoux | H. Pfeifer | W. Jung | A. Viardot | S. Maury | F. Huguet | J. Beck | N. Goekbuget | M. Alexis | S. Lissandre | F. Isnard | M. Escoffre‐Barbe | D. Heidenreich | Schaefer-Eckart Kerstin | M. Escoffre-barbe